Leading the way to safer medication
 Crosscheck  Recommender

Atorvastatin

Description

Atorvastatin is a selective, competitive inhibitor of HMG-CoA reductase. Atorvastatin lowers plasma cholesterol and lipoprotein serum concentrations by inhibiting HMG-CoA reductase and subsequently cholesterol biosynthesis in the liver and increases the number of hepatic LDL receptors on the cell surface for enhanced uptake and catabolism of LDL.

ATC Classification

Code
Title
Category
C10AA05
Atorvastatin
C Cardiovascular system → C10 Lipid modifying agents → C10A Lipid modifying agents, plain → C10AA HMG CoA reductase inhibitors

Trade names

Trade name
Countries
AMICOR

Cyprus

ATAVOR

Singapore

ATOCOR

Singapore

ATOLIPIDRIN

Austria

ATORIS

Singapore Spain

ATORNIDDA

Austria

ATORSAN

Singapore

ATORSTAN

Cyprus

ATORVACHOL

Australia

ATORVADIVID

Austria

ATORVALAN

Austria

ATORVILBITIN

Austria

ATORVON

Singapore

ATSWIFT

Singapore

BEATORVA

Singapore

CALLATOR

Austria

CARDYL

Spain

DELIPOST

Cyprus

ETURION

Singapore

INATORVAS

Singapore

LAMBRINEX

Cyprus

LIPITOR

Australia Canada Cyprus Netherlands Singapore

LORSTAT

Australia

PREVENCOR

Spain

SORTIS

Austria

TAHOR

France

THERVAN

Spain

TORVACARD

Cyprus

TORVALIPIN

Singapore

TORVASTAT

Australia

TORVATEC

Singapore

TROVAS

Australia

TULIP

Singapore

ZARATOR

Spain

Trade names (in combination): ASTUCOR ATORVALAN COMP ATOZET CADIVAST CADUET EZEATO EZETAST LIPERCOSYL LIPTRUZET ORVATEZ RESELIP TRINOMIA TRIVERAM

Product Monographs

Monograph
Type
Country
LIPITOR Film-coated tablets
MPI, EU: SmPC
UK
LIPITOR Film-coated tablet
MPI, US: SPL/PLR
US

2D Molecule Structure

3D Molecule Structure

Unique Ingredient Identifier (UNII)

A0JWA85V8F - ATORVASTATIN

CAS Registry Number

134523-00-5 - atorvastatin

SNOMED-CT

373444002 - Atorvastatin (substance)

 
Next: Usage >